Inventor · disambiguated record
Swen Hoelder
Also filed as: HOELDER SWEN
23 granted patents·2 pending applications·85 citations·filing 2001–2024
94Inventor score
Files withCANCER RESEARCH TECH LTD14SANOFI AVENTIS DEUTSCHLAND4AVENTIS PHARMA SA3AVENTIS PHARMA GMBH1CANCER REC TECH LTD1
Top patents by PatentIndex Score
25 records- 0193US11897877B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2021·Granted Feb 13, 2024·2 cites·17 claims
- 0292US9409907B2Inhibitor compoundsCANCER RES TECH LTD·Filed 2013·Granted Aug 9, 2016·14 cites·2 claims
- 0391US9890157B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Feb 13, 2018·10 cites·15 claims
- 0491US9834552B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Dec 5, 2017·8 cites·8 claims
- 0588US11046688B2Inhibitor compoundsCANCER RESEARCH TECH LTD·Filed 2019·Granted Jun 29, 2021·2 cites·19 claims
- 0686US11512095B2BCL6 inhibitorsCANCER RESEARCH TECH LTD·Filed 2019·Granted Nov 29, 2022·7 cites·20 claims
- 0786US10479788B2Compounds that inhibit MPS1 kinaseCANCER RESEARCH TECH LTD·Filed 2018·Granted Nov 19, 2019·4 cites·19 claims
- 0886US9902721B2N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitorsCANCER RESEARCH TECH LTD·Filed 2015·Granted Feb 27, 2018·7 cites·13 claims
- 0983US7727989B24-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicamentsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Jun 1, 2010·7 cites·11 claims
- 1082US10399974B2N2-phenyl-pyrido[3,4-D]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitorsCANCER RESEARCH TECH LTD·Filed 2018·Granted Sep 3, 2019·3 cites·4 claims
- 1180US11161839B22-quinolone derived inhibitors of BCL6CANCER RESEARCH TECH LTD·Filed 2018·Granted Nov 2, 2021·4 cites·19 claims
- 1280US9334286B2Pharmacologically active compoundsCANCER REC TECH LTD·Filed 2013·Granted May 10, 2016·4 cites·17 claims
- 1377US7470689B24-benzimidazol-2-ylpyridazin-3-one derivativesAVENTIS PHARMA SA·Filed 2006·Granted Dec 30, 2008·2 cites·12 claims
- 1473US6566390B2Substituted and unsubstituted benzooxathiazoles and compounds derived therefromAVENTIS PHARMA GMBH·Filed 2001·Granted May 20, 2003·5 cites·3 claims
- 1572US12110286B2Benzimidazolone derived inhibitors of BCL6CANCER RESEARCH TECH LTD·Filed 2018·Granted Oct 8, 2024·2 cites·15 claims
- 1671US9895364B2Pharmacologically active compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted Feb 20, 2018·1 cites·15 claims
- 1771US7968546B2Pyridazinone kinase inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Jun 28, 2011·1 cites·10 claims
- 1871US7709466B2Pyridazinone derivatives, methods for their production and their use as pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted May 4, 2010·1 cites·9 claims
- 1971US2024417388A1Benzimidazolone derived inhibitors of bcl6CANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 2070US7507734B2Pyridazinone derivativesAVENTIS PHARMA SA·Filed 2006·Granted Mar 24, 2009·1 cites·8 claims
- 2169US12486285B2BCL6 inhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Granted Dec 2, 2025·0 cites·22 claims
- 2263US7754713B24-benzimidazol-2-ylpyridazin-3-one derivativesAVENTIS PHARMA SA·Filed 2008·Granted Jul 13, 2010·0 cites·5 claims
- 2354US10188642B2Pharmacologically active compoundsCANCER RESEARCH TECH LTD·Filed 2017·Granted Jan 29, 2019·0 cites·15 claims
- 2454US7211592B2Substituted an unsubstituted benzooxathiazoles and compounds derived therefromSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted May 1, 2007·0 cites·6 claims
- 2552US2003191161A1Substituted and unsubstituted benzooxathiazoles and compounds derived therefromFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Swen Hoelder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →